CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN QUEBEC: MEDICATION USE IN THE LAST YEAR OF LIFE

被引：0
|
作者：
Dragomir, A. [1 ]
Vanhuyse, M. [1 ]
Cury, F. [1 ]
Aprikian, A. [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1637
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN15
引用
收藏
页码：A136 / A136
页数：1
相关论文
共 50 条
  • [31] Emerging treatment options for patients with castration-resistant prostate cancer
    George, Daniel
    Moul, Judd W.
    PROSTATE, 2012, 72 (03): : 338 - 349
  • [32] MLL translocation in two castration-resistant prostate cancer patients
    Chowdry, Rajasree Pia
    Ledet, Elisa
    Asinghe, Lahiru Ran.
    Sartor, Alton Oliver
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (05) : 8483 - 8486
  • [33] The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer
    Harshman, Lauren C.
    Werner, Lillian
    Tripathi, Abhishek
    Wang, Xiaodong
    Maughan, Benjamin L.
    Antonarakis, Emmanuel S.
    Nakabayashi, Mari
    McKay, Rana
    Pomerantz, Mark
    Mucci, Lorelei A.
    Taplin, Mary-Ellen
    Sweeney, Christopher J.
    Lee, Gwo-Shu Mary
    Kantoff, Philip W.
    PROSTATE, 2017, 77 (13): : 1303 - 1311
  • [34] Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
    Sheridan M. Hoy
    Drugs, 2013, 73 : 2077 - 2091
  • [35] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [36] Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (18) : 2077 - 2091
  • [37] Experience with fulvestrant acetate in castration-resistant prostate cancer patients
    Gasent Blesa, J. M.
    Alberola Candel, V.
    Giner Marco, V.
    Giner-Bosch, V.
    Provencio Pulla, M.
    Laforga Canales, J. B.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1131 - 1132
  • [38] IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
    Kirby, Roger S.
    Fitzpatrick, John M.
    BJU INTERNATIONAL, 2011, 107 (05) : 697 - 700
  • [39] DISEASE-SPECIFIC COSTS OF NONMETASTATIC AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN QUEBEC
    Yanev, Ivan
    Dragomir, Alice
    Vaillancourt, Zachary
    Nablsi, Emma
    Primiani, Jonathan
    Bremner, Karen
    Carcone, Steven M.
    Mitsakakis, Nicholas
    Rayan, Welson
    Krahn, Murray
    Aprikian, Armen
    JOURNAL OF UROLOGY, 2019, 201 (04): : E604 - E605
  • [40] UTILIZATION TRENDS OF NOVEL HORMONAL AGENTS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN QUEBEC
    Hu, J.
    Aprikian, A.
    Saleh, R.
    Dragomir, A.
    VALUE IN HEALTH, 2022, 25 (12) : S295 - S295
12345